{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06320717",
            "orgStudyIdInfo": {
                "id": "I-3574823"
            },
            "organization": {
                "fullName": "Roswell Park Cancer Institute",
                "class": "OTHER"
            },
            "briefTitle": "AI Derived Biomarker to Select Neoadjuvant Treatment for Borderline Resectable Pancreatic Ductal Adenocarcinoma",
            "officialTitle": "A Retrospective/Prospective Study of an Artificial Intelligence Derived Histological Biomarker to Select Neoadjuvant Treatment for Patients With Borderline Resectable or Resectable Pancreatic Ductal Adenocarcinoma",
            "therapeuticArea": [
                "Oncology and Hematology"
            ],
            "study": "ai-derived-biomarker-to-select-neoadjuvant-treatment-for-borderline-resectable-pancreatic-ductal-adenocarcinoma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-01-02",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2026-07-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-07-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-03-13",
            "studyFirstSubmitQcDate": "2024-03-13",
            "studyFirstPostDateStruct": {
                "date": "2024-03-20",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-03",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Roswell Park Cancer Institute",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To collect samples and information from patients who will be undergoing standard of care neoadjuvant treatment with either FOLFIRINOX or Gemcitabine + Nab-paclitaxel.\n\nThe information collected will be used to determine if there are any \"biomarkers\" in your blood or tumor tissue that, when compared to your response to the neoadjuvant treatment, could be used to choose the best treatment option for future patients with similar biomarkers."
        },
        "conditionsModule": {
            "conditions": [
                "Pancreatic Ductal Adenocarcinoma"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "CROSS_SECTIONAL"
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Patients with Borderline Resectable (Cohort A)",
                    "description": "Pathological response of Patients with borderline resectable disease (per NCCD Criteria) treated with standard care chemotherapy",
                    "interventionNames": [
                        "Other: Blood sample"
                    ]
                },
                {
                    "label": "Patients with Resectable (Cohort B)",
                    "description": "Pathological response of Patients with resectable disease (per NCCN criteria) treated with standard care chemotherapy",
                    "interventionNames": [
                        "Other: Blood sample"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Blood sample",
                    "description": "To determine if there are any biomarkers in the blood that could be used to choose best treatment plan for future patients",
                    "armGroupLabels": [
                        "Patients with Borderline Resectable (Cohort A)",
                        "Patients with Resectable (Cohort B)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Retrospective prediction of pCR in resectable patients",
                    "description": "Pathologic response is based on the American College of Pathology Criteria. The AI classified treatment is based on the best representative slide analyzed by the Valar Labs AI algorithm for V-FFX (is Folfirinox recommended) and V-GNP (is GEM/NAB-Paclitaxel recommended",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "Retrospective prediction of pCR in borderline resectable patients",
                    "description": "Pathologic response is based on the American College of Pathology Criteria. The AI classified treatment is based on the best representative slide analyzed by the Valar Labs AI algorithm for V-FFX (is Folfirinox recommended) and V-GNP (is GEM/NAB-Paclitaxel recommended).\n\nPathologic response is based on the American College of Pathology Criteria. The AI classified treatment is based on the best representative slide analyzed by the Valar Labs AI algorithm for V-FFX (is Folfirinox recommended) and V-GNP (is GEM/NAB-Paclitaxel recommended)",
                    "timeFrame": "Up to 2 years"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Survival status",
                    "description": "Medical chart will be reviewed for survival status",
                    "timeFrame": "Up to 2 years"
                },
                {
                    "measure": "RECIST 1.1 response",
                    "description": "Tumor response was determined by RECIST1.1",
                    "timeFrame": "UP to 2 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Have histologically or cytologically confirmed PDAC that is borderline resectable (BR) (Cohort A) OR have histologically or cytologically confirmed PDAC that is resectable (Cohort B) using the National Comprehensive Cancer Network criteria \\[35\\].\n* Availability of archival tumor tissue (diagnostic for PDAC) required\n* Have a documented ECOG Performance Status of \u2264 1\n* Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form (ICF) prior to receiving any study related procedure.\n\nExclusion Criteria:\n\n* Has received prior systemic treatment (standard of care or experimental) for PDAC\n* Participant has a concurrent malignancy requiring active treatment during the study.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "community practices and hospital clinics",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Christos Fountzilas, MD",
                    "role": "CONTACT",
                    "phone": "716-845-2300",
                    "email": "Christos.Fountzilas@roswellpark.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Christos Fountilas, MD",
                    "affiliation": "Roswell Park Comprehensive Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Roswell Park Comprehensive Cancer Center",
                    "status": "RECRUITING",
                    "city": "Buffalo",
                    "state": "New York",
                    "zip": "14263",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.88645,
                        "lon": -78.87837
                    }
                },
                {
                    "facility": "Good Samaritan University Hospital",
                    "status": "RECRUITING",
                    "city": "West Islip",
                    "state": "New York",
                    "zip": "11795",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "John Loscalzo, MD",
                            "role": "CONTACT",
                            "phone": "631-417-8600"
                        },
                        {
                            "name": "John Loscalzo, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.70621,
                        "lon": -73.30623
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000000230",
                    "term": "Adenocarcinoma"
                }
            ],
            "ancestors": [
                {
                    "id": "D000002277",
                    "term": "Carcinoma"
                },
                {
                    "id": "D000009375",
                    "term": "Neoplasms, Glandular and Epithelial"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M3585",
                    "name": "Adenocarcinoma",
                    "asFound": "Adenocarcinoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5534",
                    "name": "Carcinoma",
                    "relevance": "LOW"
                },
                {
                    "id": "M12320",
                    "name": "Neoplasms, Glandular and Epithelial",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        }
    },
    "hasResults": false
}